Cross-Market Implications in FTC’s Anesthesia Complaint
The authors discuss how precedents from this case could potentially provide a framework under which the FTC will challenge mergers.
Resale Price Maintenance & the Digital Age
Nathaniel Hipsman will moderate a panel of practitioners, economists, and government enforcement officials at this American Bar Association event.
The Global Antitrust Economics Conference
Rainer Schwabe and Anand Krishnamurthy will join competition experts to discuss the role of financial services and life sciences in antitrust.
FTC v. US Anesthesia Partners: Serial Acquisitions and Private Equity in Focus
Laurien Gilbert will moderate a panel of attorneys to discuss the role of private equity firms in healthcare.
GCR Live: Women in Antitrust 2023
Avigail Kifer will join a panel titled, “Novel Theories of How Mergers Harm Competition” at this annual conference in Washington, DC.
Global Class Actions Symposium 2023
Vikram Kumar will chair a panel about calculating damages in large class actions at this London conference.
John Asker Appointed to New Australian Competition Taskforce Advisory Panel
Professor Asker joins an expert panel appointed to advise the Australian government on potential changes to the country's competition policy settings.
Bid Rigging and Umbrella Damages
This article analyzes the role of umbrella damages when conducting damage assessment in bid-rigging cases.
IBA 2023: International Bar Association Annual Conference
Joanna Tsai will speak on a panel titled “The Boundaries of Unilateral Conduct” at this annual conference in Paris.
Value Drug Company v. Takeda Pharmaceuticals U.S.A. Inc. et al.
Laurence Baker testified during a rare antitrust trial centering on the allegation that a brand manufacturer conspired with three generics to allocate the market for gout medication colchicine.
How can we help you?
If you are looking for a publication not on our website, contact us.